. Author manuscript; available in PMC: 2015 May 4.

Published in final edited form as: J Pharm Pharmacol (Los Angel). 2015 Jan 10;2(2):8. doi: 10.13188/2327-204X.1000011

Table 1.

Solubility enhancement of PTX-CD complexes.

Sr. No.	Batch	PTX:CD (molar)	PTX Solubility μg/mL	Solubility Enhancement
1	N/A	N/A	0.38	N/A
2	HPCD1	1:1	154.43	406.1 ± 3.8
3	HPCD2	1:2	190.98	502.6 ± 2.4^*
4	HPCD5	1:5	204.37	537.8 ± 2.3^*
5	MeCD1	1:1	155.72	409.7 ± 0.6
6	MeCD2	1:2	138.21	363.7 ± 0.6
7	MeCD5	1:5	178.98	471.1 ± 0.7^#
8	SBCD1	1:1	156.57	412.1 ± 2.6
9	SBCD2	1:2	162.08	426.7 ± 0.8^§
10	SBCD5	1:5	160.58	422.6 ± 1.3^§

P<0.05 when compared to HPCD1

P<0.05 when compared with MeCD1

^§

P<0.05 when compared with SBCD1